Literature DB >> 3326434

Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.

A C Prost1, N Abuaf, A M Rouquette-Gally, J C Homberg, A Combrisson.   

Abstract

The comparative study of the human tumor cell line HEp-2 and rat liver for the detection of antinuclear and antinucleolar autoantibodies by the indirect immunofluorescence technic in routine screening test demonstrate that, taking titer and staining pattern into account, both substrates are able to separate autoimmune disease (systemic lupus erythematosus, rheumatoid arthritis, scleroderma and primary biliary cirrhosis) patients from healthy subjects. The minimal screening test must include sera diluted 1:20 and 1:80. The capability of the HEp-2 substrate to reveal and to discriminate different speckled nuclear and nucleolar patterns explain its greater performance, notably in detecting anticentromere antibodies highly specific for the CREST syndrome and a speckled nuclear antibody frequently associated with primary biliary cirrhosis, allowing an earlier diagnosis of autoimmune diseases presenting these patterns.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326434

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  4 in total

1.  Measurement of antinuclear antibodies: assessment of different test systems.

Authors:  P Kern; M Kron; K Hiesche
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.

Authors:  P Muratori; L Muratori; F Cassani; P Terlizzi; M Lenzi; L Rodrigo; F B Bianchi
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.

Authors:  Yoshihiro Hirata; Atsushi Yoshizawa; Hiroto Egawa; Daisuke Ueda; Shinya Okamoto; Hideaki Okajima; Kimiko Yurugi; Rie Hishida; Hideyo Hirai; Aya Miyagawa-Hayashino; Taira Maekawa; Hironori Haga; Sinji Uemoto
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

4.  Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.

Authors:  May Y Choi; Jing Cui; Karen Costenbader; David Rydzewski; Lisa Bernhard; Peter Schur
Journal:  Lupus Sci Med       Date:  2020-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.